NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead.
Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year.
Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet.
That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict.
Dame Judi Dench's tears as she receives Sycamore Gap tree seedling at Chelsea Flower Show
Lea Michele showcases baby bump in figure
SAMANTHA BRICK: I'm a brilliant driver
Sudanese paramilitary forces have carried out ethnic cleansing in Darfur, rights group says
Not so Cool Britannia! Noel Gallagher gives damning verdict on Keir Starmer
John Leguizamo reveals he TURNED DOWN Stanley Tucci's role in The Devil Wears Prada
Map reveals Britain's worst crash hotspots outside of London
Will Levis sees the Titans' offseason additions as proof team wants to win now
US overdose deaths dropped in 2023, the first time since 2018
Kim Kardashian was 'booed by Dave Portnoy fans' during Tom Brady roast
Australia, New Zealand send planes to evacuate nationals from New Caledonia
Inside Instagram 'bully' Katherine Asplundh's extravagant wedding to billionaire husband